Join
Live feed
·
PRReleasevia Quantisnow
Amneal Pharmaceuticals Inc. logo

Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AMRX (Amneal Pharmaceuticals Inc.) and more on Quantisnow.